Effect of immune-enhancing enteral nutrition formula enriched with plant-derived n-3 fatty acids on natural killer cell activity in rehabilitation patients

키워드

참고문헌 (49)

1. Corrigan ML, "Nutrition in the stroke patient", Nutr Clin Pract, 26, pp.242~252 (2011)
2. Wirth R, "Guideline clinical nutrition in patients with stroke", Exp Transl Stroke Med, 5, pp.14~ (2013)
3. Liu H, "Clinical application of immune-enhanced enteral nutrition in patients with advanced gastric cancer after total gastrectomy", J Dig Dis, 13, pp.401~406 (2012)
4. Seike J, "The effect of nutritional support on the immune function in the acute postoperative period after esophageal cancer surgery: total parenteral nutrition versus enteral nutrition", J Med Invest, 58, pp.75~80 (2011)
5. Calder PC, "Rationale and use of n-3 fatty acids in artificial nutrition", Proc Nutr Soc, 69, pp.565~573 (2010)
6. Ruxton CH, "The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence", J Hum Nutr Diet, 17, pp.449~459 (2004)
7. Hardin-Fanning F, "Polyunsaturated fatty acids. Immunomodulators in older adults", J Gerontol Nurs, 37, pp.20~28 (2011)
8. Kim YS, "Impact of dietary components on NK and Treg cell function for cancer prevention", Mol Carcinog, 54, pp.669~678 (2015)
9. Beale RJ, "Immunonutrition in the critically ill: a systematic review of clinical outcome", Crit Care Med, 27, pp.2799~2805 (1999)
10. Heys SD, "Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials", Ann Surg, 229, pp.467~477 (1999)
11. Heyland DK, "Should immunonutrition become routine in critically ill patients? A systematic review of the evidence", JAMA, 286, pp.944~953 (2001)
12. Zheng Y, "Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials", Asia Pac J Clin Nutr, 16(Suppl 1), pp.253~257 (2007)
13. Ma C, "Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): A prospective, randomized, double-blind study", J Postgrad Med, 64, pp.155~163 (2018)
14. Lochs H, "Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics", Clin Nutr, 25, pp.180~186 (2006)
15. Snyderman CH, "Reduced postoperative infections with an immune-enhancing nutritional supplement", Laryngoscope, 109, pp.915~921 (1999)
16. Kudsk KA, "A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications", Ann Surg, 224, pp.531~543 (1996)
17. Weimann A, "ESPEN guideline: clinical nutrition in surgery", Clin Nutr, 36, pp.623~650 (2017)
18. Sydnor ER, "Hospital epidemiology and infection control in acute-care settings", Clin Microbiol Rev, 24, pp.141~173 (2011)
19. Khanapure SP, "Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers", Curr Top Med Chem, 7, pp.311~340 (2007)
20. Massaro M, "The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibition", Proc Natl Acad Sci U S A, 103, pp.15184~15189 (2006)
21. Thomas DR, "Nutritional management in long-term care: development of a clinical guideline", J Gerontol A Biol Sci Med Sci, 55, pp.M725~M734 (2000)
22. Bankhead R, "Enteral nutrition practice recommendations", JPEN J Parenter Enteral Nutr, 33, pp.122~167 (2009)
23. United States Department of Agriculture, "Composition of Foods Raw, Processed, Prepared - USDA National Nutrient Database for Standard Reference, Release 28", USDA, ~ (2005)
24. World Health Organization, "Global Database on Body Mass Index: an Interactive Surveillance Tool for Monitoring Nutrition Transition", WHO, ~ (2012)
25. Sprecher H, "The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids", Prostaglandins Leukot Essent Fatty Acids, 67, pp.79~83 (2002)
26. Yaqoob P, "Fatty acids and immune function: new insights into mechanisms", Br J Nutr, 98(Suppl 1), pp.S41~S45 (2007)
27. Calder PC, "The relationship between the fatty acid composition of immune cells and their function", Prostaglandins Leukot Essent Fatty Acids, 79, pp.101~108 (2008)
28. Weiss G, "Immunomodulation by perioperative administration of n-3 fatty acids", Br J Nutr, 87(Suppl 1), pp.S89~S94 (2002)
29. Barrett AH, "Effect of various antioxidants, antioxidant levels, and encapsulation on the stability of fish and flaxseed oils: assessment by fluorometric analysis", J Food Process Preserv, 35, pp.349~358 (2011)
30. Kolanowski W, "Enrichment of food products with polyunsaturated fatty acids by fish oil addition", Eur Food Res Technol, 222, pp.472~477 (2006)
31. Kolanowski W, "Possibilities of fish oil application for food products enrichment with omega-3 PUFA", Int J Food Sci Nutr, 50, pp.39~49 (1999)
32. Moretta A, "What is a natural killer cell?", Nat Immunol, 3, pp.6~8 (2002)
33. Forel JM, "Phenotype and functions of natural killer cells in critically-ill septic patients", PLoS One, 7, pp.e50446~ (2012)
34. Calder PC, "Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients", Braz J Med Biol Res, 36, pp.433~446 (2003)
35. Wada M, "Enzymes and receptors of prostaglandin pathways with arachidonic acidderived versus eicosapentaenoic acid-derived substrates and products", J Biol Chem, 282, pp.22254~22266 (2007)
36. Souza-Fonseca-Guimaraes F, "Natural killer (NK) cells in antibacterial innate immunity: angels or devils?", Mol Med, 18, pp.270~285 (2012)
37. Narni-Mancinelli E, "Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses", Science, 335, pp.344~348 (2012)
38. Kreymann KG, "ESPEN guidelines on enteral nutrition: intensive care", Clin Nutr, 25, pp.210~223 (2006)
39. Drewry AM, "Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study", Crit Care, 20, pp.334~ (2016)
40. Kjaergaard AG, "Expression of NK cell and monocyte receptors in critically ill patients--potential biomarkers of sepsis", Scand J Immunol, 81, pp.249~258 (2015)
41. Hall MW, "Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome", Intensive Care Med, 37, pp.525~532 (2011)
42. Hall MW, "Innate immune function and mortality in critically ill children with influenza: a multicenter study", Crit Care Med, 41, pp.224~236 (2013)
43. Lee JG, "Effect of immune-enhancing enteral nutrition enriched with or without beta-glucan on immunomodulation in critically ill patients", Nutrients, 8, pp.336~ (2016)
44. Lee DH, "Agedependent alterations in serum cytokines, peripheral blood mononuclear cell cytokine production, natural killer cell activity, and prostaglandin F2α", Immunol Res, 65, pp.1009~1016 (2017)
45. Flick DA, "Pharmacokinetics of murine tumor necrosis factor", J Immunopharmacol, 8, pp.89~97 (1986)
46. Hayes KC, "Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury", J Neurotrauma, 19, pp.753~761 (2002)
47. Agarwal N, "Correlation of tumour necrosis factor-α and interleukin-6 with anthropometric indices of obesity and parameters of insulin resistance in healthy north Indian population", J Indian Acad Clin Med, 12, pp.196~204 (2011)
48. Jason J, "Comparison of serum and cell-specific cytokines in humans", Clin Diagn Lab Immunol, 8, pp.1097~1103 (2001)
49. Nordenström J, "Metabolic utilization of intravenous fat emulsion during total parenteral nutrition", Ann Surg, 196, pp.221~231 (1982)

관련 논문AI추천